口腔医学研究2024,Vol.40Issue(12) :1121-1124.DOI:10.13701/j.cnki.kqyxyj.2024.12.018

阿替利珠和贝伐珠单抗诱发口腔苔藓样药物反应及牙龈出血1例

Oral Lichenoid Drug Reactions and Gingival Bleeding Induced by Atezolizumab and Bevacizumab:A Case Report

李佳琪 李鑫磊 周刚
口腔医学研究2024,Vol.40Issue(12) :1121-1124.DOI:10.13701/j.cnki.kqyxyj.2024.12.018

阿替利珠和贝伐珠单抗诱发口腔苔藓样药物反应及牙龈出血1例

Oral Lichenoid Drug Reactions and Gingival Bleeding Induced by Atezolizumab and Bevacizumab:A Case Report

李佳琪 1李鑫磊 1周刚1
扫码查看

作者信息

  • 1. 口颌系统重建与再生全国重点实验室,口腔生物医学教育部重点实验室,口腔医学湖北省重点实验室,武汉大学口腔医(学)院口腔黏膜科 湖北武汉 430079
  • 折叠

摘要

口腔苔藓样药物反应(oral lichenoid drug reactions,OLDR)是指过敏体质者使用特定药物后引起口腔黏膜苔藓样表现的疾病.诱发OLDR的药物种类繁多,由免疫治疗诱发的口腔苔藓样药物反应临床上报道较少.本文报道了1例由阿替利珠和贝伐珠单抗联合抗癌治疗诱发的口腔苔藓样药物反应及牙龈出血,探讨该疾病的临床特点及诊治原则,以期为临床上此类疾病的诊疗提供参考.

Abstract

Oral lichenoid drug reactions(OLDR)refer to lichenoid manifestation of the oral mucosa induced by specific drugs in individuals with allergic predispositions.There are numerous types of drugs that can trigger OLDR,but reports on oral lichenoid drug reactions induced by immunotherapy are rare.This manuscript reports a case of OLDR and gingival bleeding induced by atezolizumab and bevacizumab combination anticancer therapy,and explores its clinical features,as well as the diagnostic and treatment approaches.The aim of this case is to provide valuable insights for the clinical management of this disease.

关键词

口腔苔藓样药物反应/阿替利珠单抗/贝伐珠单抗/免疫相关不良事件

Key words

oral lichenoid drug reactions/atezolizumab/bevacizumab/immune-related adverse events

引用本文复制引用

出版年

2024
口腔医学研究
武汉大学口腔医学院

口腔医学研究

CSTPCDCSCD北大核心
影响因子:0.48
ISSN:1671-7651
段落导航相关论文